APOG Stock Analysis: Apogee Enterprises | NASDAQ
Building Products & Equipment | NASDAQ, USA | Market Cap: 811m USD | 12M Return: -8.4% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 12.8M
EPS Trend: -71.5%
Qual. Beats: 1
Rev. Trend: -23.4%
Qual. Beats: 2
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Apogee Enterprises (NASDAQ: APOG) is a Minneapolis-based provider of architectural products and services for building enclosures, along with glass and acrylic products used for preservation, protection, and viewing applications. The company operates through four reportable segments-Architectural Metals (aluminum window, curtainwall, storefront, and entrance systems under brands such as Tubelite, EFCO, and Linetec), Architectural Glass (custom window and wall glass under Viracon), Architectural Services (curtainwall and façade design, engineering, fabrication, and installation under Harmon), and Performance Surfaces (coated materials for wall decor, museums, displays, and architectural interiors under brands including Tru Vue and ChromaLuxe). Operations span the United States, Canada, and Brazil.
The companys offerings are primarily sold into non-residential construction, including commercial buildings (offices, hotels, retail), institutional facilities (education, healthcare, government), and transportation terminals, as well as multi-family residential projects. Distribution is conducted through a direct sales force, independent sales representatives, distributors, glazing subcontractors, and general contractors, reflecting a predominantly business-to-business go-to-market model typical of the Building Products sub-industry within the Industrials sector. Apogee was incorporated in 1949 and has been publicly traded since its 1978 IPO.
- Non-residential construction demand drives Architectural Metals backlog
- Commercial office weakness pressures curtainwall project margins and volumes
- Performance Surfaces segment expands margins with coated product growth
| Net Income: 68.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA 5.62 > 1.0 |
| NWC/Revenue: 13.26% < 20% (prev 14.15%; Δ -0.89% < -1%) |
| CFO/TA 0.14 > 3% & CFO 149.7m > Net Income 68.4m |
| Net Debt (312.0m) to EBITDA (155.7m): 2.00 < 3 |
| Current Ratio: 1.76 > 1.5 & < 3 |
| Outstanding Shares: last quarter (21.3m) vs 12m ago -0.12% < -2% |
| Gross Margin: 23.34% > 18% (prev 25.20%; Δ -1.86% > 0.5%) |
| Asset Turnover: 124.1% > 50% (prev 119.0%; Δ 5.10% > 0%) |
| Interest Coverage Ratio: 8.14 > 6 (EBIT TTM 105.5m / Interest Expense TTM 13.0m) |
| A: 0.17 (Total Current Assets 430.4m - Total Current Liabilities 244.6m) / Total Assets 1.10b |
| B: 0.34 (Retained Earnings 374.1m / Total Assets 1.10b) |
| C: 0.09 (EBIT TTM 105.5m / Avg Total Assets 1.13b) |
| D: 0.87 (Book Value of Equity 512.0m / Total Liabilities 589.4m) |
| Altman-Z'' = 3.75 = AA |
| DSRI: 0.95 (Receivables 251.5m/259.4m, Revenue 1.40b/1.38b) |
| GMI: 1.08 (GM 25.20% / 23.34%) |
| AQI: 1.03 (AQ_t 0.34 / AQ_t-1 0.33) |
| SGI: 1.02 (Revenue 1.40b / 1.38b) |
| TATA: -0.07 (NI 68.4m - CFO 149.7m) / TA 1.10b) |
| Beneish M = -2.97 (Cap -4..+1) = A |
As of July 15, 2026, the stock is trading at USD 38.53 with a total of 258,905 shares traded. Over the past week, the price has changed by -0.44%, over one month by -3.10%, over three months by +8.18% and over the past year by -8.35%.
Current recommended Stop Loss: 35.20 (which is 8.6% or 1.7 ATR below the current price).
Apogee Enterprises has received a consensus analysts rating of 5.00. Therefore, it is recommended to buy APOG.
- StrongBuy: 1
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 44 | 14.2% |
P/E Trailing = 12.1818
P/E Forward = 14.4092
P/S = 0.5789
P/B = 1.5622
P/EG = 1.2008
Revenue TTM = 1.40b USD
EBIT TTM = 105.5m USD
EBITDA TTM = 155.7m USD
Long Term Debt = 237.4m USD (from longTermDebt, last quarter)
Short Term Debt = 14.7m USD (from shortTermDebt, last quarter)
Debt = 338.4m USD (from shortLongTermDebtTotal, last quarter) + Leases 50.5m
Net Debt = 312.0m USD (calculated: Debt 338.4m - CCE 26.4m)
Enterprise Value = 1.12b USD (810.9m + Debt 338.4m - CCE 26.4m)
Interest Coverage Ratio = 8.14 (Ebit TTM 105.5m / Interest Expense TTM 13.0m)
EV/FCF = 9.11x (Enterprise Value 1.12b / FCF TTM 123.2m)
FCF Yield = 10.98% (FCF TTM 123.2m / Enterprise Value 1.12b)
FCF Margin = 8.80% (FCF TTM 123.2m / Revenue TTM 1.40b)
Net Margin = 4.88% (Net Income TTM 68.4m / Revenue TTM 1.40b)
Gross Margin = 23.34% ((Revenue TTM 1.40b - Cost of Revenue TTM 1.07b) / Revenue TTM)
Gross Margin QoQ = 21.89% (prev 22.73%)
Tobins Q-Ratio = 1.02 (Enterprise Value 1.12b / Total Assets 1.10b)
Interest Expense / Debt = 3.83% (Interest Expense 13.0m / Debt 338.4m)
Taxrate = 24.87% (22.6m / 91.0m)
NOPAT = 79.3m (EBIT 105.5m * (1 - 24.87%))
Current Ratio = 1.76 (Total Current Assets 430.4m / Total Current Liabilities 244.6m)
Debt / Equity = 0.66 (Debt 338.4m / totalStockholderEquity, last quarter 512.0m)
Debt / EBITDA = 2.00 (Net Debt 312.0m / EBITDA 155.7m)
Debt / FCF = 2.53 (Net Debt 312.0m / FCF TTM 123.2m)
Total Stockholder Equity = 509.1m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.05% (Net Income 68.4m / Total Assets 1.10b)
RoE = 13.43% (Net Income TTM 68.4m / Total Stockholder Equity 509.1m)
RoCE = 14.14% (EBIT 105.5m / Capital Employed (Equity 509.1m + L.T.Debt 237.4m))
RoIC = 9.38% (NOPAT 79.3m / Invested Capital 845.2m)
WACC = 7.34% (E(810.9m)/V(1.15b) * Re(9.20%) + D(338.4m)/V(1.15b) * Rd(3.83%) * (1-Tc(0.25)))
Discount Rate = 9.20% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -91.09 | Cagr: -1.60%
[DCF] Terminal Value 77.97% ; FCFF base≈99.7m ; Y1≈114.3m ; Y5≈168.2m
[DCF] Fair Price = 106.4 (EV 2.53b - Net Debt 312.0m = Equity 2.22b / Shares 20.9m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -71.54 | EPS CAGR: -12.54% | SUE: 0.97 | # QB: 1
Revenue Correlation: -23.42 | Revenue CAGR: -0.35% | SUE: 1.27 | # QB: 2
EPS current Quarter (2026-08-31): EPS=0.64 | Chg30d=+0.00% | Revisions=-25% | Analysts=2
EPS next Quarter (2026-11-30): EPS=0.80 | Chg30d=-5.33% | Revisions=+25% | Analysts=2
EPS current Year (2027-02-28): EPS=2.87 | Chg30d=+2.14% | Revisions=+25% | GrowthEPS=-17.4% | GrowthRev=+1.3%
EPS next Year (2028-02-29): EPS=3.90 | Chg30d=+5.41% | Revisions=+25% | GrowthEPS=+36.1% | GrowthRev=+7.3%
[Analyst] Revisions Ratio: +29% (up=3, down=1)